Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
David Bravo
CEO
david@pannextherapeutics.com

Message the company or request a 1:1 meeting here

Pannex Therapeutics is a biopharmaceutical company totally focused on Pannexin 1 channel (Panx1) blockers, an exciting new therapeutic class. With a platform of small molecules blocking Panx1 channels, we are pioneering this new therapeutic class, with potential applications in many therapeutic areas. As the first target indication, the company is developing a first-in-class, selective and highly potent oral Panx1 channel blocker, for the treatment of chronic pain and prevention of opioid addiction.

Pitch Video

Slide Deck

Executive Summary